ArticleFrontiers in pediatrics2026
Case Report: Prolonged extracorporeal membrane oxygenation as a deliberate operative adjunct for tracheobronchial reconstruction in a child with invasive aspergillosis.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 6-year-old boy with newly diagnosed type 1 diabetes mellitus presenting in diabetic ketoacidosis, who developed a massive acquired tracheo-esophageal fistula (TEF) with extensive destruction of the tracheobronchial anatomy, including near-complete loss of the left main bronchus, secondary to invasive mediastinal aspergillosis. The clinical course was complicated by refractory respiratory failure and subsequent right ventricular failure, necessitating prolonged extracorporeal membrane oxygenation (ECMO) support totaling 96 days. The patient required veno-venous ECMO, followed by temporary conversion to veno-arterial ECMO to stabilize hemodynamics during profound atelectasis and pulmonary hypertension, before returning to veno-venous support until decannulation. Definitive airway reconstruction was achieved using a vascularized autologous esophageal muscular flap in a severely inflamed and infected operative field where prosthetic materials were contraindicated, with planned sacrifice of esophageal continuity to prioritize airway restoration. Antifungal therapy was initiated following histopathological confirmation of Aspergillus hyphae and adjusted in response to hepatic dysfunction. Postoperatively, intentional lung rest for 14 days, with gas exchange maintained entirely by ECMO, protected the fragile membranous reconstruction. Despite multiple life-threatening complications, survival with satisfactory neurological outcome was achieved through close multidisciplinary cooperation. This case illustrates the role of ECMO as a bridge to complex airway reconstruction in pediatric patients with destructive invasive fungal disease, and describes the esophageal muscular wall flap as an autologous salvage option for posterior tracheobronchial defects in infected mediastinal fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.